BeStock  
Stocks › Biotechnology › PRAX

Praxis Precision Medicines PRAX

US equityMarket cap rank #1557Biotechnology
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

PRAX at a glance

PRAX is priced at $300.43 right now, down 3.37% on the session. That puts its market value at $8.40B, 1557th largest among the 3753 stocks we cover.

Over the past 52 weeks it has traded between $167.32 and $392.70, so it sits 23.5% below the top of that range. Holders are ahead 76.9% over twelve months, but down 18.4% across the last three months.

Price is above the 50-day average ($286.09) but below the 200-day ($314.52); RSI is 51, and the last 30 sessions moved at roughly 80% annualized volatility.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, and a net loss of $94.23M.

12 analysts follow the stock and the average call is "buy". The mean target, $728.33, sits 142.4% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$301.00 / $325.00
Average price today$304.90
Volume806.2KAvg (90d) 458.7K
Turnover$245.80M
Turnover rate3.34%of shares outstanding
Volume ratio1.36vs. recent average pace
Day amplitude5.02%
Market cap$8.40B
Float market cap$7.24B
Shares outstanding24.11M
EPS (TTM)-$13.48
P/B6.67
Book value / share$45.06
Net profit (TTM)-$376.79M
Net assets$1.26B
30-day volatility80.1%annualized
Avg daily range (ATR)7.07%of price, 14 days
Max drawdown (1y)-38.1%-22.2% from 1y peak

Quote as of Nov 22, 2026 5:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

12 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 48.3 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability2.5
Momentum48.6
Financial health79.4
Analyst view92.6

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$728.33+142.4% vs. current price
Consensus ratingBuy12 analysts covering
Morningstar fair value$325.07Price is below fair value

Wall Street’s average 12-month target is $728.33, 142.4% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $325.07, so shares trade 7.6% below that estimate. On earnings multiple, it sits in the 3rd percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-3.4%
1 week
-8.4%
1 month
+16.0%
3 months
-18.4%
6 months
-12.6%
Year to date
+1.9%
1 year
+76.9%
Day range
$298.54$314.15
52-week range
$167.32$392.70

Technical signals

Full technicals →
Trend readLeaning bullish

5 bullish · 2 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+0.5%Bullish
Price vs 50-day average+5.0%Bullish
Price vs 200-day average-4.5%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)51.0Bullish
MACD (12,26,9)8.45Bullish
Bollinger band position52%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How PRAX ranks on BeStock

Market value#1553 of 3734
Closeness to 52-week high#1749 of 3724
Dollar volume today#557 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

PRAX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on PRAX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on PRAX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

PRAX stock: common questions

How is Praxis Precision Medicines stock doing today?

$300.43 is the latest print for PRAX, a move of -3.37% against yesterday's close of $310.90. Today's low and high so far: $298.54 and $314.15.

How large is Praxis Precision Medicines by market value?

Equity value comes to $8.40B at the current price. By that measure it is number 1557 of the 3753 names in our coverage.

Where does PRAX sit in its 52-week range?

The year's floor is $167.32 and the ceiling $392.70. Shares are 23.5% away from that ceiling.

Does PRAX send cash back through a dividend?

Our data shows no dividend paid by Praxis Precision Medicines over the trailing twelve months.

Do Wall Street analysts like PRAX?

Of 12 analysts, 92% say buy, 8% hold and 0% sell. Price targets average $728.33, with the most cautious at $343.00 and the most optimistic at $1,201.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on PRAX.

Sign in to join the discussion.

Scroll to Top